Stryker (NYSE:SYK) said yesterday that it closed its acquisition of Arrinex and its Clarifix cryoablation technology intended for treating chronic rhinitis. Kalamazoo, Mich.-based Stryker said that Menlo Park, Calif.-based Arrinex was founded in 2013 and began commercializing the Clarifix technology in late 2017. Stryker said that the acquisition will expand its ENT portfolio and that the … Continue reading Stryker closes Arrinex buy